Companies / Spruce Biosciences
Spruce Biosciences
United States
Spruce Biosciences develops and commercializes novel therapies for neurological and endocrine disorders with significant unmet medical need
Spruce Biosciences, based in United States, has 4 investors on file, among them Aisling Capital, HealthCap and Omega Funds.
SEC Form D filings
4 filingsFiled by SPRUCE BIOSCIENCES, INC. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
1 headline naming Spruce BiosciencesEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Spruce Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Aisling Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/sprucebiosciences.com/investors
# also
GET /v1/companies/sprucebiosciences.com
GET /v1/companies/sprucebiosciences.com/news